Get started
Range Cancer Therapeutics ETFRange Cancer Therapeutics ETFRange Cancer Therapeutics ETF

Range Cancer Therapeutics ETF

No trades
See on Supercharts
Overview Analysis
Holdings
News Ideas Discussions Technicals Seasonals

Range Cancer Therapeutics ETF holdings


As of April 10, 2025
Symbol
Weight %
Shares
Shares Chg %
1M
Market value
Market value Chg %
1M
T
TSVT2seventy Bio, Inc.
1.97%
‪‪25.73 K‬‬
−21.35%
‪‪127.65 K‬‬USD
+39.32%
S
SMMTSummit Therapeutics Inc
1.96%
‪‪6.33 K‬‬
+18.50%
‪‪127.51 K‬‬USD
+32.73%
F
FATEFate Therapeutics, Inc.
1.90%
‪‪131.83 K‬‬
+231.70%
‪‪123.29 K‬‬USD
+234.70%
D
DNAGinkgo Bioworks Holdings, Inc. Class A
1.84%
‪‪16.39 K‬‬
−35.10%
‪‪119.68 K‬‬USD
−31.83%
E
EXELExelixis, Inc.
1.83%
‪‪3.44 K‬‬
−39.95%
‪‪118.58 K‬‬USD
−47.15%
B
BNTXBioNTech SE Sponsored ADR
1.81%
‪‪1.26 K‬‬
−0.94%
‪‪117.61 K‬‬USD
−12.44%
Y
YMABY-mAbs Therapeutics, Inc.
1.79%
‪‪26.76 K‬‬
+121.21%
‪‪116.41 K‬‬USD
+102.16%
I
IPHAInnate Pharma SA Sponsored ADR
1.77%
‪‪62.75 K‬‬
−13.68%
‪‪114.84 K‬‬USD
−23.32%
B
BPMCBlueprint Medicines Corp.
1.71%
‪‪1.38 K‬‬
−24.18%
‪‪111.01 K‬‬USD
−29.79%
G
GMABGenmab A/S Sponsored ADR
1.70%
‪‪6.12 K‬‬
+3.43%
‪‪110.29 K‬‬USD
−15.23%
Get deeper insights with ETF data
Explore detailed ETF holdings data, including weight, shares, and market value.